Overactive bladder symptoms following urethrolysis procedures

Leach GE, Dmochowski RR, Appell RA, et al.: Female Stress Urinary Incontinence Guidelines panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. J Urol 1997, 158:875–880. Jeffry L, Deval B, Birsan A, et al.: Objective and subjective cure rates after tension-free vaginal tape for treatment of stress urinary incontinence. Urology 2001, 58:702–706. Nilsson CG, Kuuva N, Falconer C, et al.: Long-term results of the tension-free vaginal tape procedure for surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2001, 12:S5. Barber MD, Gustilo-Ashby AM, Chen CC, et al.: Perioperative complications and adverse events of the MONARC transobturator tape, compared with tension-free vaginal tape. Am J Obstet Gynecol 2006, 195:1820–1825. Holmgren C, Nilsson S, Lanner L, et al.: Frequency of de novo urgency in 463 women who had undergone the tension-free vaginal tape (TVT) procedure for genuine stress urinary incontinence—a long-term follow-up. Eur J Obstet Gynecol Reprod Biol 2007, 132:1121–1125. Botros SM, Miller JJ, Goldberg RP, et al.: Detrusor overactivity and urge urinary incontinence following transobturator vs retropubic midurethral slings. Neurourol Urodyn 2007, 26:42–45. Botros SM, Abramov Y, Goldberg RP, et al.: Detrusor overactivity and urge urinary incontinence following midurethral vs bladder neck slings. J Obstet Gynecol 2005, 193:2144–2148. Daneshgari F, Kong W, Swartz M: Complications of midurethral slings: important outcomes for future clinical trials. J Urol 2008, 180:1890–1897. Kershen RT, Appell RA: De novo urge syndrome and detrusor instability after anti-incontinence surgery: current concepts, evaluation and treatment. Curr Urol Rep 2002, 3:345–353. De Groat WC: A neurologic basis for the overactive bladder. Urology 1997, 50:36–52. Coolsaet BL, Van Duyl WA, Van Os-Bossagh P, et al.: New concepts in relation to urge and detrusor overactivity. Neurourol Urodyn 1993, 12:463–471. Drake MJ, Harvey IJ, Gillespie JI, et al.: Localized contractions in the normal human bladder and in urinary urgency. BJU Int 2005, 95:1002–1005. Turner WH, Brading AF: Smooth muscle of the bladder in the normal and the diseased state: pathophysiology, diagnosis, and treatment. Pharmacol Ther 1997, 75:77–110. De Groat WC: The urothelium in overactive bladder: passive bystander or active participant? Urology 2004, 64:7–11. Drake MJ, Mills IW, Gillespie JI, et al.: Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet 2001, 358:401–403. Starkman JS, Scarpero HM, Dmochowski RR: Methods and results of urethrolysis. Curr Urol Rep 2006, 7:384–394. Gomelsky A, Nitti VW, Dmochowski RR. Management of obstructive voiding dysfunction after incontinence surgery: lessons learned. Urology 2003, 62:391–399. Speakman MJ, Brading AF, Gilpin CJ, et al.: Bladder outflow obstruction—a cause for denervation supersensitivity. J Urol 1987, 138:1461–1466. Calvert RC, Thompson CS, Khan MA, et al.: Alterations in cholinergic and purinergic signaling in a model of the obstructed bladder. J Urol 2001, 166:1530–1533. Mitterberger M, Pallwein L, Gradl J, et al.: Persistent detrusor overactivity after transurethral resection of the prostate is associated with reduced perfusion of the urinary bladder. BJU Int 2007, 99:831–835. Borirakchanyavat S, Baskin LS, Kogan BA, et al.: Smooth and striated muscle development in the intrinsic urethral sphincter. J Urol 1997, 158:1119–1122. Ball TP Jr, Teichman JM, Sharkey FE, et al.: Terminal nerve distribution to the urethra and bladder neck: considerations in the management of stress urinary incontinence. J Urol 1997, 158:827–829. Hijaz A, Bena J, Daneshgari F: Long-term efficacy of a vaginal sling procedure in a rat model of stress urinary incontinence. J Urol 2005, 173:1817–1819. Carr LK, Webster GD: Voiding dysfunction following incontinence surgery: diagnosis and treatment with retropubic or vaginal urethrolysis. J Urol 1997, 157:821–823. Nitti VW: Evaluation of the female with neurogenic voiding dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 1999, 10:119–129. Chassagne S, Bernier PA, Haab F, et al.: Proposed cutoff values to define bladder outlet obstruction in women. Urology 1998, 51:408–411. Lemack GE, Zimmern PE: Pressure flow analysis may aid in identifying women with outflow obstruction. J Urol 2000, 163:1823–1828. Defreitas GA, Zimmern PE, Lemack GE, et al.: Diagnosis of anatomic female bladder outlet obstruction: comparison of pressure-flow study parameters in clinically obstructed women with those of normal controls. Urology 2004, 64:675–679. Blaivas JG, Groutz A: Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn 2000, 19:553–564. Aikikwala TV, Fleischman N, Nitti VW: Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol 2006, 176:2093–2097. Alperin M, Abrahams-Gessel S, Wakamatsu MM: Development of de novo urge incontinence in women post sling: the role of preoperative urodynamics in assess risk. Neurourol Urodyn 2008, 27:407–411. Gamble TL, Botros SM, Beaumont JL, et al.: Predictors of persistent detrusor overactivity after transvaginal sling procedures. Am J Obstet Gynecol 2008, 199:696. e1–696.e7. Deng D, Rutman M, Raz S, et al.: Presentation and management of major complications of midurethral slings: are complications under-reported? Neurourol Urodyn 2007, 26:46–52. Dunn JS Jr, Bent AE, Ellerkman RM, et al.: Voiding dysfunction after surgery for stress incontinence: literature review and survey results. Int Urogynecol J Pelvic Floor Dysfunct 2004, 15:25–31. Webster GD, Kreder K: Voiding dysfunction following cystourethropexy: evaluation and management. J Urol 1990, 144:670–673. Nitti VW, Carlson KV, Blaivas JG, et al.: Early results of pubovaginal sling lysis by midline sling incision. Urology 2002, 59:47–51. Goldman HB: Simple sling incision for the treatment of iatrogenic urethral obstruction. Urology 2003, 62:714–718. Cross CA, Cespedes RD, English SF, et al.: Transvaginal urethrolysis for urethral obstruction after anti-incontinence surgery. J Urol 1998, 159:1199–1201. Nitti VW, Raz S: Obstruction following anti-incontinence procedures: diagnosis and treatment with transvaginal urethrolysis. J Urol 1994, 152:93–98. McCrery R: Transvaginal urethrolysis for obstruction after anti-incontinence surgery. Int Urogynecol J Pelvic Floor Dysfunct 2006, 18:1251–1257. Segal J, Steele A, Vassallo B, et al.: Various surgical approaches to treat voiding dysfunction following antiincontinence surgery. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17:372–377. Starkman JS, Wolter CE, Kaufman MR, et al.: The evolution of obstruction-induced overactive bladder symptoms following urethrolysis for female bladder outlet obstruction. J Urol 2008, 179:1018–1023. Starkman JS, Wolter C, Gomelsky A, et al.: Voiding dysfunction following removal of eroded synthetic midurethral slings. J Urol 2006, 176:1040–1044. Huang KH, Kung FT, Liang HM, et al.: Management of polypropylene mesh erosions after intravaginal midurethral sling operation for female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2005, 16:437–440. Amundsen CL, Flynn BJ, Webster GD: Urethral erosion after synthetic and nonsynthetic pubovaginal slings: differences in management and continence outcome. J Urol 2003, 170:134–137. Clemens JQ, DeLancey JO, Faerber GJ, et al.: Urinary tract erosions after synthetic pubovaginal slings: diagnosis and management strategy. Urology 2000, 56:589–594. Sweat SD, Itano NB, Clemens JQ, et al.: Polypropylene mesh tape for stress urinary incontinence: complications of urethral erosion and outlet obstruction. J Urol 2002, 168:144–146. Leng WW, Davies BJ, Tarin T, et al.: Delayed treatment of bladder outlet obstruction after sling surgery: association with irreversible bladder dysfunction. J Urol 2004, 172:1379–1381. South MM, Wu JM, Webster GD, et al.: Early vs late midline sling lysis results in greater improvement in lower urinary tract symptoms. Am J Obstet Gynecol 2009, 200:564.e1–564.e5. Ballert KN, Biggs GY, Nitti VW: Antimuscarinic agents. In AUA Update Series 2008, vol 27. Linthicum, MD: American Urological Association; 2008:138–147. Scarpero HM, Dmochowski RR, Nitti VW: Repeat urethrolysis after failed urethrolysis for iatrogenic obstruction. J Urol 2003, 169:1013–1016. Siegel SW, Catanzaro F, Dijkema HE, et al.: Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency/frequency, and urinary retention. Urology 2000, 56(6 Suppl 1):87–91. Spinelli M, Giardiello G, Gerber M, et al.: New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol 2003, 170:1905–1907. Sherman ND, Jamison MG, Webster GD, et al.: Sacral neuromodulation for the treatment of refractory urinary urge incontinence after stress incontinence surgery. Am J Obstet Gynecol 2005, 193:2083–2087. Starkman JS, Wolter CE, Scarpero HM, et al.: Management of refractory urinary urge incontinence following urogynecological surgery with sacral neuromodulation. Neurourol Urodyn 2007, 26:29–35. Smith CP, Chancellor MB: Botulinum toxin: clinical uses in urology. In AUA Update Series 2008, vol 27. Linthicum, MD: American Urological Association; 2008:126–135. Khera M, Somogyi GT, Kiss S, et al.: Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 2004, 45:987–993. Aoki KR: Review of proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005, 26:785–793. Rapp DE, Turk KW, Bales GT, et al.: Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder. J Urol 2006, 175:1138–1142. Schurch B, Stohrer M, Kramer G, et al.: Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000, 164:692–697. Schmid DM, Sauermann P, Werner M, et al.: Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 2006, 176:177–185.